|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8704 USD | +2.40% |
|
+10.61% | +22.33% |
| Jun. 29 | Tenaya Therapeutics, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Jun. 29 | Tenaya Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective July 13, 2026 | CI |
Company Valuation: Tenaya Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 782.3 | 128.6 | 220.7 | 113.3 | 154 | 184.4 | - | - |
| Change | - | -83.56% | 71.58% | -48.67% | 35.98% | 19.74% | - | - |
| Enterprise Value (EV) 1 | 531 | -75.61 | 116 | 51.84 | 53.5 | 88.35 | 56.21 | 100.1 |
| Change | - | -114.24% | 253.46% | -55.33% | 3.2% | 65.14% | -36.38% | 78.07% |
| P/E | -4.62x | -0.73x | -1.93x | -1.09x | -1.21x | -2.13x | -1.91x | 2.72x |
| PBR | 2.81x | 0.55x | 1.71x | 1.31x | 1.25x | 1.49x | 1.98x | 3.54x |
| PEG | - | 0x | 0x | 0x | 0x | 0.1x | -0.2x | -0x |
| Capitalization / Revenue | - | - | - | - | - | 21.7x | - | 0.66x |
| EV / Revenue | - | - | - | - | - | 10.4x | - | 0.36x |
| EV / EBITDA | -7.94x | 0.63x | -0.95x | -0.48x | -0.63x | -0.99x | -0.51x | -0.71x |
| EV / EBIT | -7.29x | 0.6x | -0.88x | -0.45x | -0.57x | -1.01x | -0.53x | 0.72x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -4.1 | -2.76 | -1.68 | -1.31 | -0.59 | -0.3986 | -0.445 | 0.3125 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 8.508 | - | 277.9 |
| EBITDA 1 | -66.9 | -119.2 | -122.5 | -107.5 | -84.9 | -89.32 | -110.2 | -140.9 |
| EBIT 1 | -72.81 | -125.6 | -131.2 | -115.9 | -93.33 | -87.19 | -106.6 | 139.7 |
| Net income 1 | -72.72 | -123.7 | -124.1 | -111.1 | -90.6 | -85.78 | -108.8 | 120.5 |
| Net Debt 1 | -251.3 | -204.2 | -104.6 | -61.45 | -100.5 | -96.1 | -128.2 | -84.36 |
| Reference price 2 | 18.9500 | 2.0100 | 3.2400 | 1.4300 | 0.7115 | 0.8500 | 0.8500 | 0.8500 |
| Nbr of stocks (in thousands) | 41,281 | 63,988 | 68,111 | 79,221 | 216,506 | 216,999 | - | - |
| Announcement Date | 3/23/22 | 3/8/23 | 3/18/24 | 3/10/25 | 3/11/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13x | 10.38x | -0.99x | - | 184M | |
| 35.02x | 6.15x | 19.02x | 0.94% | 50.44B | |
| -23.93x | 350.56x | -22.64x | -.--% | 40.63B | |
| 25.43x | 2.81x | 12.14x | -.--% | 34.88B | |
| 46.36x | 4.58x | 29.24x | -.--% | 33.67B | |
| 26.73x | 7.84x | 19.68x | 0.43% | 26.29B | |
| 31.59x | 5.09x | 23.2x | -.--% | 15.29B | |
| -17.76x | 11.63x | -17.23x | -.--% | 10.62B | |
| 23.89x | 2.03x | 8.94x | 1.12% | 13.74B | |
| Average | 16.13x | 44.56x | 7.93x | 0.31% | 25.08B | |
| Weighted average by Cap. | 20.23x | 67.53x | 10.00x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TNYA Stock
- Valuation Tenaya Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
